Africa Western and Central vs Switzerland: Access to anti-retroviral drugs, male
Africa Western and Central
74.2%
in 2024
Switzerland
90.0%
in 2023
Africa Western and Central rank
13th
Switzerland rank
13th
Access to anti-retroviral drugs, male over time
- Africa Western and Central
- Switzerland
How they compare
Switzerland currently reports 90.0% against 74.2% in Africa Western and Central, a difference of 15.8%.
That makes Switzerland's figure about 1.2 times Africa Western and Central's.
Across all 24 years both countries report, Switzerland has been ahead every year.
Africa Western and Central ranks 13th and Switzerland ranks 13th of 19 groups.
Switzerland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Africa Western and Central | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.7% | 50.0% | 45.3% | Switzerland |
| 2010s | 28.1% | 79.2% | 51.1% | Switzerland |
| 2020s | 58.4% | 90.2% | 31.8% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Africa Western and Central or Switzerland?
- Switzerland, at 90.0% against 74.2% in Africa Western and Central as of 2023.
- What is the difference in access to anti-retroviral drugs, male between Africa Western and Central and Switzerland?
- 15.8%, with Switzerland ahead.
- How many years of comparable data are there for Africa Western and Central and Switzerland?
- 24 years are reported by both, from 2000 to 2023.
- How do Africa Western and Central and Switzerland rank globally for access to anti-retroviral drugs, male?
- Africa Western and Central ranks 13th and Switzerland ranks 13th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.